GLAXO - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 19 Sept 25, 2:16 pm

Technical Rating: 3.5

Here’s a detailed technical analysis of GlaxoSmithKline Pharmaceuticals Ltd (GLAXO)

📉 Trend Analysis

Current Price (₹2,749) is below both 50-DMA (₹2,881) and 200-DMA (₹2,803) — indicating a bearish trend.

52-week Index at 51.9% shows the stock is trading in the mid-range of its yearly band (₹1,921–₹3,516), suggesting loss of momentum from earlier highs.

Trend Status: Reversing downward, with no clear signs of recovery yet.

🔍 Momentum Indicators

RSI (43.4): In the neutral-to-weak zone, approaching oversold territory — signals lack of momentum and caution.

MACD (-34.0): Deeply negative — confirms bearish divergence and short-term weakness.

Volume: At 1.13L, slightly above 1-week average (1.06L) — suggests mild activity, but not enough to reverse trend.

📊 Chart Patterns & Moving Averages

Price is trading below key moving averages, reinforcing bearish sentiment.

Support Levels

₹2,700 (recent swing low)

₹2,600 (psychological support)

Resistance Levels

₹2,881 (50-DMA)

₹2,950–₹3,000 (gap zone and psychological resistance)

📉 Bollinger Bands

Price is near the lower band, indicating oversold conditions.

Bands are contracting, suggesting low volatility and potential for a sharp move once volume returns.

🎯 Entry & Exit Zones

Action Price Zone (₹) Rationale

Entry 2,700–2,740 Near support zone and lower band

Exit (Short-Term) 2,880–2,950 Resistance zone, potential reversal

Stop Loss 2,600 Below psychological support

🧭 Summary

Trend: Reversing downward

Momentum: Weak and bearish

Volatility: Low, with bounce potential

Ideal Strategy: Cautious accumulation near ₹2,700–₹2,740 with target ₹2,880–₹2,950. Wait for MACD flattening and RSI rebound above 50 for confirmation.

Would you like to compare this setup with other pharma or defensive sector stocks for broader positioning?

Edit in a page